Astellas Pharma Inc (ALPMY)
10.94
-0.12
(-1.08%)
USD |
OTCM |
Mar 27, 16:00
Astellas Pharma Gross Profit (Quarterly): 2.344B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.344B |
September 30, 2023 | 2.200B |
June 30, 2023 | 2.230B |
March 31, 2023 | 2.210B |
December 31, 2022 | 2.325B |
September 30, 2022 | 2.299B |
June 30, 2022 | 2.261B |
March 31, 2022 | 2.109B |
December 31, 2021 | 2.386B |
September 30, 2021 | 2.390B |
June 30, 2021 | 2.411B |
March 31, 2021 | 2.363B |
December 31, 2020 | 2.463B |
September 30, 2020 | 2.343B |
June 30, 2020 | 2.298B |
March 31, 2020 | 2.362B |
December 31, 2019 | 2.348B |
September 30, 2019 | 2.312B |
June 30, 2019 | 2.399B |
March 31, 2019 | 2.152B |
December 31, 2018 | 2.428B |
September 30, 2018 | 2.200B |
June 30, 2018 | 2.369B |
March 31, 2018 | 2.265B |
December 31, 2017 | 2.387B |
Date | Value |
---|---|
September 30, 2017 | 2.233B |
June 30, 2017 | 2.190B |
March 31, 2017 | 2.078B |
December 31, 2016 | 2.285B |
September 30, 2016 | 2.337B |
June 30, 2016 | 2.466B |
March 31, 2016 | 2.100B |
December 31, 2015 | 2.273B |
September 30, 2015 | 2.173B |
June 30, 2015 | 2.090B |
March 31, 2015 | 1.853B |
December 31, 2014 | 2.255B |
September 30, 2014 | 2.080B |
June 30, 2014 | 2.146B |
March 31, 2014 | 1.961B |
December 31, 2013 | 2.233B |
September 30, 2013 | 1.973B |
June 30, 2013 | 1.907B |
March 31, 2013 | 1.777B |
December 31, 2012 | 2.253B |
September 30, 2012 | 1.994B |
June 30, 2012 | 2.118B |
March 31, 2012 | 1.621B |
December 31, 2011 | 2.411B |
September 30, 2011 | 2.079B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
2.109B
Minimum
Mar 2022
2.463B
Maximum
Dec 2020
2.310B
Average
2.334B
Median
Gross Profit (Quarterly) Benchmarks
Daiichi Sankyo Co Ltd | 2.198B |
Takeda Pharmaceutical Co Ltd | 4.956B |
Eisai Co Ltd | 998.97M |
Sosei Group Corp | 15.24M |
PeptiDream Inc | 71.09M |